Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.33 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | MMP3 | P08254 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2073043 | 1.00 | PPARD (0.46) | PPARDMCL1KMT2ATBXA2RS1PR5 | |
| SCHEMBL2073038 | 1.00 | PPARD (0.46) | PPARDMCL1KMT2ATBXA2RS1PR5 | |
| SCHEMBL12828067 | 0.84 | PPARD (0.48) | PPARDMCL1KMT2AS1PR5AKR1C3 | |
| SCHEMBL1471222 | 0.82 | KMT2A (0.41) | PPARDKMT2ACA12CA1CA2 | |
| SCHEMBL4740697 | 0.82 | KMT2A (0.41) | PPARDKMT2ACA12CA1CA2 | |
| SCHEMBL1470495 | 0.82 | KMT2A (0.41) | PPARDKMT2ACA12CA1CA2 | |
| SCHEMBL12749903 | 0.81 | PPARD (0.46) | PPARDMCL1KMT2AS1PR5GAA | |
| SCHEMBL4020417 | 0.78 | NOS3 (0.43) | PPARDKMT2ANOS3AKR1C3AKR1C1 | |
| SCHEMBL27765587 | 0.76 | — | — | |
| SCHEMBL1471127 | 0.74 | PPARD (0.50) | PPARDKMT2AAKR1C3NOTUMMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9463189-B2 | Sulfonyl-substituted bicyclic compounds as PPAR modulators for the treatment of non-alcoholic steatohepatitis | BPV HOLDINGS, LLC (US) | 2016-10-11 | — | — | US | disclosed |
| US-20130252970-A1 | SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | KALYPSYS, INC. (US) | 2013-09-26 | — | — | US | disclosed |
| US-7863276-B2 | Salts of modulators of PPAR and methods of treating metabolic disorders | KALYPSYS, INC (US) | 2011-01-04 | — | — | US | disclosed |
| WO-2008091863-A1 | SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | KALYPSYS, INC. (US) | 2008-07-31 | — | — | WO | disclosed |
| US-20080176861-A1 | SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | KALYPSYS, INC. (US) | 2008-07-24 | — | — | US | disclosed |
| EP-1940815-A1 | SALTS OF MODULATORS OF PPAR AND METHODS OF TREATING METABOLIC DISORDERS | Kalypsys, Inc. (US) | 2008-07-09 | — | — | EP | disclosed |
| WO-2008043024-A2 | ORAL PHARMACEUTICAL FORMULATION COMPRISING A SULFONYL BICYCLIC MODULATOR OF PPAR FOR THE TREATMENT OF DISEASE | KALYPSYS, INC. (US) | 2008-04-10 | — | — | WO | disclosed |
| US-20080004281-A1 | METHODS FOR THE MODULATION OF CRP BY THE SELECTIVE MODULATION OF PPAR DELTA | KALYPSYS, INC. (US) | 2008-01-03 | — | — | US | disclosed |
| US-20070249519-A1 | METHODS FOR THE UPREGULATION OF GLUT4 VIA MODULATION OF PPAR DELTA IN ADIPOSE TISSUE AND FOR THE TREATMENT OF DISEASE | KALYPSYS, INC. (US) | 2007-10-25 | — | — | US | disclosed |
| WO-2007051095-A1 | SALTS OF MODULATORS OF PPAR AND METHODS OF TREATING METABOLIC DISORDERS | KALYPSYS, INC. (US) | 2007-05-03 | — | — | WO | disclosed |
| US-20070093504-A1 | Salts of Modulators Of PPAR and Methods of Treating Metabolic Disorders | KALYAPSYS, INC. (US) | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093504-A1 | Salts of Modulators Of PPAR and Methods of Treating Metabolic Disorders | PPARG, PPARA, PPARD | PPARD 3/4885MCL1 3085/4885KMT2A 3530/4885 |
| US-20080176861-A1 | SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | PPARD, PPARG, PPARA | PPARD 1/4885MCL1 4554/4885KMT2A 2765/4885 |
| US-20070249519-A1 | METHODS FOR THE UPREGULATION OF GLUT4 VIA MODULATION OF PPAR DELTA IN ADIPOSE TISSUE AND FOR THE TREATMENT OF DISEASE | FABP4, PPARG, PPARA | PPARD 6/4885MCL1 4816/4885KMT2A 4387/4885 |
| US-20080004281-A1 | METHODS FOR THE MODULATION OF CRP BY THE SELECTIVE MODULATION OF PPAR DELTA | PPARD, PPARA, PPARG | PPARD 1/4885MCL1 3907/4885KMT2A 4191/4885 |
| US-20130252970-A1 | SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | PPARD, PPARG, PPARA | PPARD 1/4885MCL1 4554/4885KMT2A 2765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.